↓ Skip to main content

Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis

Overview of attention for article published in Frontiers in oncology, June 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis
Published in
Frontiers in oncology, June 2022
DOI 10.3389/fonc.2022.939969
Pubmed ID
Authors

Cristina Di Giorgio, Silvia Marchianò, Elisabetta Marino, Michele Biagioli, Rosalinda Roselli, Martina Bordoni, Rachele Bellini, Ginevra Urbani, Angela Zampella, Eleonora Distrutti, Annibale Donini, Luigina Graziosi, Stefano Fiorucci

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 25%
Student > Ph. D. Student 1 13%
Unknown 5 63%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Biochemistry, Genetics and Molecular Biology 1 13%
Engineering 1 13%
Unknown 5 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2022.
All research outputs
#15,181,325
of 25,392,582 outputs
Outputs from Frontiers in oncology
#4,558
of 22,436 outputs
Outputs of similar age
#199,111
of 441,098 outputs
Outputs of similar age from Frontiers in oncology
#302
of 1,759 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,098 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 1,759 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.